NCT05070871View on ClinicalTrials.gov

A Clinical Trial Investigating the Effect of Salmon Bone Meal on Osteoarthritis Among Men and Women

NACompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

September 22, 2021

Primary Completion Date

December 27, 2023

Study Completion Date

January 15, 2024

Conditions
OsteoarthritisOsteoarthritis, KneeOsteoarthritis, Hip
Interventions
DIETARY_SUPPLEMENT

Hydrolyzed Collagen

Hydrolyzed collagen type II derived from the bone powder of Norwegian Atlantic salmon.

OTHER

Placebo

Pure maltodextrin.

DIETARY_SUPPLEMENT

CalGo

CalGo is a natural marine collagenic bone powder from salmon. The bone powder is a 100 % microcrystalline hydroxyapatite form of calcium and collagen type 2.

Trial Locations (3)

6005

Hofseth Biocare ASA, Ålesund

6508

Kristiansund Hospital, Kristiansund

0456

Lovisenberg Diakonale Sykehus, Oslo

All Listed Sponsors
collaborator

Møre og Romsdal Hospital Trust

OTHER

lead

Hofseth Biocare ASA

INDUSTRY

NCT05070871 - A Clinical Trial Investigating the Effect of Salmon Bone Meal on Osteoarthritis Among Men and Women | Biotech Hunter | Biotech Hunter